Pfizer and Department for Promotion of Industry and Internal Trade (DPIIT) have signed Memorandum of Understanding (MoU). The collaboration aims to accelerate the lab-to-market journey of innovative healthcare products by extending both financial and non-financial support to startups. Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs 60 lakh each, along with a tailored 18-month incubation program delivered by Social Alpha. The program will provide dedicated acceleration tracks covering clinical validation, regulatory approvals, and go-to-market strategies. 

Startups will also gain access to expert mentorship, infrastructure, and global networks, in addition to exposure at Pfizer’s Research and Development facilities in Chennai, enabling them to strengthen innovations with advanced industry insights.

The initiative will support 14 pioneering MedTech startups innovating in screening, diagnostics, health monitoring, and treatment enablers, with a particular focus on non-communicable diseases, oncology, brain health, maternal and child health, and immunisation.

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.